UNSPSC 51453400: Anthelmintic terpenes

Anthelmintic drugs made from a class of compounds composed of repeating 5-carbon units of hemiterpenes.

UNSPSC 51453400 Anthelmintic terpenes is a Class code, but the recent state and local opportunities tagged under it do not address anthelmintic terpenes or parasiticide drugs. Instead, the code shows activity in pharmaceutical procurement, naloxone distribution, medical and first aid supplies for emergency response, and generic multi-source pharmaceutical supply through cooperative purchasing agreements. The scope of work being solicited spans naloxone and drug deactivation systems for public health initiatives, emergency medical supplies for fire rescue operations, and bulk generic pharmaceuticals and OTC products for state and local health systems. Issuing bodies include state health and human services departments, county health offices, municipal fire departments, and multi-state cooperative purchasing alliances. The state of Florida (Seminole County), Texas (Health and Human Services Commission), Minnesota (through MMCAP), and Oregon (as a MMCAP participant) appear in recent activity. This code shows a mismatch between its nominal scope and actual recent procurement activity — the opportunities are not purchasing anthelmintic agents but rather broader pharmaceutical and medical supply categories.

Representative recent solicitations include Seminole County, Florida's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries; the City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first aid supplies for the Fire Department Rescue Division with an estimated contract value of $700,000 and a certified Small Local Business Enterprise set-aside offering a 5 percent bid discount; and MMCAP's RFP S1070000015802 (posted January 20, 2026, due March 26, 2026) for generic multi-source pharmaceuticals and OTC products with contracts effective July 1, 2026, distributed through three authorized wholesalers across multiple state and local jurisdictions. The Texas Health and Human Services Commission also issued RFI HHS0017013 (posted April 3, 2026) to explore direct-to-manufacturer pharmacy programs. Vendors should verify that opportunities tagged under this code align with their actual product and service lines before pursuing.